

LONDON (Alliance News) - GW Pharmaceuticals PLC said Friday its Dravet syndrome treatment Epidiolex had been granted 'Fast Track' status by the US Foo...


LONDON (Alliance News) - GW Pharmaceuticals PLC Wednesday said it expects to start a phase II/III clinical trial for developmental childhood Epilepsy ...


LONDON (Alliance News) - The FTSE 100 lost ground Tuesday, snapping a five day winning streak as investors returned from a long weekend, over which th...